Olema Pharmaceuticals (OLMA) Revenue & Revenue Breakdown
Olema Pharmaceuticals Revenue Highlights
Olema Pharmaceuticals Revenue by Period
Olema Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | - |
Olema Pharmaceuticals generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Olema Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $1.88M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | - |
Olema Pharmaceuticals generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Olema Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| FENC | Fennec Pharmaceuticals | $21.64M | $25.26M |
| MOLN | Molecular Partners | $7.04M | $2.74M |
| CNTA | Centessa Pharmaceuticals | $6.88M | - |
| OBIO | Orchestra BioMed | $2.76M | $778.00K |
| LIFE | aTyr Pharma | $353.00K | $235.00K |
| DSGN | Design Therapeutics | - | - |
| CGEM | Cullinan Oncology | - | - |
| ANTX | AN2 Therapeutics | - | - |
| GRCL | Gracell Bio | - | - |
| PHVS | Pharvaris | - | - |
| IRON | Disc Medicine | - | - |
| OLMA | Olema Pharmaceuticals | - | - |
| ERAS | Erasca | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| LRMR | Larimar Therapeutics | - | - |
| SANA | Sana Bio | - | - |
| NVCT | Nuvectis Pharma | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
| ZNTL | Zentalis Pharmaceuticals | - | - |
| PEPG | PepGen | - | - |
OLMA Revenue FAQ
What is Olema Pharmaceuticals’s yearly revenue?
Olema Pharmaceuticals's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. OLMA's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Olema Pharmaceuticals’s quarterly revenue?
Olema Pharmaceuticals's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). OLMA's quarterly revenue for Q4 2023 was $1.88M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Olema Pharmaceuticals’s revenue growth rate?
Olema Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.